Asporin and osteoarthritis

Area of Science:

• Biochemistry
• Molecular Biology
• Rheumatology

Background:

• Asporin is a Class I small leucine-rich proteoglycan (SLRP) with a distinct structure.
• Accumulating evidence suggests asporin's involvement in osteoarthritis (OA) pathogenesis.

Purpose of the Study:

• To review the current literature on the role of asporin in osteoarthritis.
• To explore potential mechanisms linking asporin to OA pathology.

Main Methods:

• A narrative review of existing literature was conducted.
• Literature search focused on asporin's role in OA and related genetic polymorphisms.

Main Results:

• Human studies on asporin D-repeat polymorphisms and OA susceptibility yielded inconsistent results.
• Potential mechanisms involve asporin's influence on transforming growth factor-β (TGF-β) signaling and collagen mineralization.
• No studies utilized an asporin-deficient animal model to elucidate disease mechanisms.

Conclusions:

• Asporin is involved in OA pathogenesis, with proposed mechanisms including TGF-β pathway modulation.
• Large-scale, interracial studies are necessary to confirm the association between asporin and OA.
• Further research is crucial for understanding OA mechanisms, developing therapeutic strategies, and diagnostic approaches.